Company · CIK 1850902
Alpha Teknova, Inc.
| CIK | 1850902 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2835 — In Vitro & In Vivo Diagnostic Substances |
| Incorporated in | DE |
| Business address | CA |
| Listed | TKNO (Nasdaq) |
| First annual or quarterly report | 2021-08-13 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-288613 | 2025-07-10 | 2026-10-21 | 4 | |
| 333-281765 | 2024-08-23 | 2024-08-29 | 2 | |
| 333-275168 | 2023-10-25 | 2023-11-07 | 2 | |
| 333-265987 | 2022-07-01 | 2023-09-19 | 4 | |
| 333-256795 | 2021-06-04 | 2021-06-25 | 4 |
Filings
17| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-10-21 | 424B5Shelf takedown | 333-288613 | 0001193125-26-427916 |
| 2026-10-20 | 424B5Shelf takedown | 333-288613 | 0001193125-26-426674 |
| 2025-07-16 | EFFECTDeclared effective | 333-288613 | 9999999995-25-002267 |
| 2025-07-10 | S-3Shelf registered | 333-288613 | 0001193125-25-157628 |
| 2024-08-29 | EFFECTDeclared effective | 333-281765 | 9999999995-24-002690 |
| 2024-08-23 | S-1Registration filed | 333-281765 | 0001193125-24-206239 |
| 2023-11-07 | EFFECTDeclared effective | 333-275168 | 9999999995-23-003237 |
| 2023-10-25 | S-1Registration filed | 333-275168 | 0001193125-23-263115 |
| 2023-09-19 | 424B5Shelf takedown | 333-265987 | 0001193125-23-237665 |
| 2023-03-30 | 424B5Shelf takedown | 333-265987 | 0001193125-23-085766 |
| 2022-07-12 | EFFECTDeclared effective | 333-265987 | 9999999995-22-002044 |
| 2022-07-01 | S-3Shelf registered | 333-265987 | 0001193125-22-187223 |
| 2021-06-25 | 424B4Final prospectus | 333-256795 | 0001193125-21-200510 |
| 2021-06-24 | EFFECTDeclared effective | 333-256795 | 9999999995-21-002500 |
| 2021-06-21 | S-1/AAmendment | 333-256795 | 0001193125-21-194075 |
| 2021-06-04 | S-1Registration filed | 333-256795 | 0001193125-21-182919 |
| 2021-04-05 | DRSDraft made public | 377-04587 | 0000950123-21-004208 |